BiomedicalMedical Technology in an Age of Robots
Transforming Biology in the Second Machine Age
Biomedical technology is transforming the way we heal and augment the human body. This is an exciting age of technological advances in the world of neuroscience and medical technology in general. This department tracks what is happening on the medical front.
She called it “probably the least ethical thing on the planet, right now.” The she is Elizabeth Parrish, CEO of BioViva . The it is bioethics. n the context of my “Ending Aging” interview with Parrish (AOR,...
This is confirmed by the international journal Ultrasound in Medicine and Biology. Researchers at SINTEF, NTNU and St. Olavs Hospital at the National Competence Service for ultrasound and image processing have long been working on the use of 3D ultrasound in various clinical procedures.
With a four-year $1.4 million grant from the National Institutes of Health (NIH), two University of Houston engineering professors are developing a home test kit for kidney nephritis, or inflammation, in patients who have Systemic Lupus Erythematosus. The Test Kit Uses a Smartphone to Test for Kidney Inflammation.
Here’s an open invitation to steal. It goes out to cancer fighters and tempts them with a new program that predicts cancer drug effectiveness via machine learning and raw genetic data. The researchers who built the program at the Georgia Institute of Technology would like cancer fighters to take it for free, or even just swipe parts of their programming code, so they’ve made it open source.
With smartphones millions of times more powerful than the NASA Apollo computers that sent us to the moon in the 1960s, scientists have been eager to adapt them back here on Earth to better the planet. That’s exactly what ASU Biodesign Institute researcher Tony Hu and postdoctoral researcher Dali Sun have recently demonstrated.
Nanobots that patrol our bodies, killer immune cells hunting and destroying cancer cells, biological scissors that cut out defective genes: these are just some of technologies that Cambridge researchers are developing which are set to revolutionise medicine in the future.
A multidisciplinary group that includes the University of Illinois at Urbana-Champaign and the University of Washington at Tacoma has developed a novel platform to diagnose infectious disease at the point-of-care, using a smartphone as the detection instrument in conjunction with a test kit in the format of a credit card.
During more than 60,000 hours of combined use of a novel artificial pancreas system, participants in a 12-week, multi-site clinical trial showed significant improvements in two key measures of well-being in people living with type 1 diabetes.
Some anti-cancer drugs are encapsulated to allow gradual release, spreading their effect over a longer time. For example, one formulation of the chemotherapy doxorubicin ( the FDA-approved drug Doxil®) encloses molecules of the drug in fatty nano-spheres called liposomes, which allows the drug to circulate longer in the blood. However, the use of liposome “capsules” often comes with side-effects.
Working with mice and rats, Johns Hopkins researchers have developed a way to successfully deliver nano-sized, platinum-based chemotherapy drugs to treat a form of bladder cancer called nonmuscle-invasive that is found in the lining of the organ and has not invaded deeper into bladder tissue.
Biomedical Department Head
This position is open for someone in the biomedical field.